Literature DB >> 9806729

The diagnostic relevance of red cell rigidity.

R Banerjee1, K Nageshwari, R R Puniyani.   

Abstract

Red cell rigidity is an important hemorheological parameter determining the passage of erythrocyte through narrow capillaries and the reduction of blood viscosity under high shear rates. The changes in red cell rigidity in various diseases of altered blood flow - hypertension (HT), diabetes mellitus (DM), myocardial infarction (MI) and cerebrovascular accidents (CVA), using equal sample sizes of 25 each, have been analysed in this paper. One of the essential elements of red cell rigidity is the structural and functional properties of erythrocyte membrane which, in turn, is determined by the membrane biochemistry. Since cholesterol-rich erythrocytes have increased rigidity, the serum cholesterol and triglycerides levels have been monitored in order to detect the extent to which they affect red cell rigidity. No significant change in red cell rigidity have been found in CVA. RBC rigidity is found to be significantly increased in the other diseases. Significant increase in triglyceride levels have been found in all the diseases studied. Cholesterol levels were significantly increased in all diseases except CVA. Hence, increased cholesterol levels have been found to consistently cause a simultaneous increase in RBC rigidity. Triglycerides levels, on the other hand, have not shown a consistent change with changes in RBC rigidity, but have been shown to be a more sensitive marker for early detection of diseased status.

Entities:  

Mesh:

Year:  1998        PMID: 9806729

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  9 in total

1.  Intravenous injection of mesenteric lymph produced during hemorrhagic shock decreases RBC deformability in the rat.

Authors:  Michael Condon; Maheswari Senthil; Da-Zhong Xu; Leonard Mason; Sharvil U Sheth; Zoltan Spolarics; Eleonora Feketova; George W Machiedo; Edwin A Deitch
Journal:  J Trauma       Date:  2011-02

2.  Alteration of alpha-spectrin ubiquitination after hemorrhagic shock.

Authors:  Kimberly Caprio; Michael R Condon; Edward A Deitch; Da-Zhang Xu; Eleonora Feketova; George W Machiedo
Journal:  Am J Surg       Date:  2008-11       Impact factor: 2.565

3.  Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes.

Authors:  Kathryn C Gersh; Chandrasekaran Nagaswami; John W Weisel
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

4.  The relationship between red blood cell deformability metrics and perfusion of an artificial microvascular network.

Authors:  Jose M Sosa; Nathan D Nielsen; Seth M Vignes; Tanya G Chen; Sergey S Shevkoplyas
Journal:  Clin Hemorheol Microcirc       Date:  2014       Impact factor: 2.375

5.  Haemorheological variables in a rat model of hypertriglyceridaemic obesity and diabetes.

Authors:  G N Herńandez; C Dabin; M del C Gayol; M L Rasia
Journal:  Vet Res Commun       Date:  2002-12       Impact factor: 2.459

6.  Interaction of graphene nanoribbons with components of the blood vascular system.

Authors:  Sayan Mullick Chowdhury; Justin Fang; Balaji Sitharaman
Journal:  Future Sci OA       Date:  2015-06-02

7.  Determination of red blood cell deformability using centrifugal force in a three-dimensional-printed mini-disk (3D-PMD).

Authors:  Hyunjung Lim; Seung Min Back; Jeonghun Nam; Hyuk Choi
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

8.  Microscopic Monitoring of Erythrocytes Deformation under Different Shear Stresses Using Computerized Cone and Plate Flow Chamber: Analytical Study of Normal Erythrocytes and Iron Deficiency Anemia.

Authors:  Mohamed A Elblbesy
Journal:  Biomed Res Int       Date:  2018-10-24       Impact factor: 3.411

9.  RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability.

Authors:  Marijke Grau; Sebastian Pauly; Jamal Ali; Katja Walpurgis; Mario Thevis; Wilhelm Bloch; Frank Suhr
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.